Position in QGEN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$3,706,542
-$4,242,804 QoQ
Shares Held
92,571
-47.6% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Edgestream Partners, L.P. holds $7,616,279 across 5 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
10,841 | $2,458,630 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
1,863 | $2,380,001 | |
| 3 | LH |
Labcorp Holdings Inc.
|
5,885 | $1,647,800 | |
| 4 | TWST |
Twist Bioscience Corp
|
5,992 | $616,456 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
1,024 | $513,392 |
All Filings in QGEN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,706,542 | 92,571 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $7,949,346 | 176,770 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,079,490 | 113,686 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $3,028,594 | 75,432 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $942,524 | 20,683 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,369,570 | 33,331 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,491,924 | 34,704 | Shares | Sole | 2024-05-10 | |
| 2023-09-30 | $2,500,093 | 59,817 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,540,268 | 33,145 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,721,199 | 57,410 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $2,452,516 | 57,570 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||